Concentric Capital Strategies’s Boston Scientific BSX Stock Holding History

Concentric Capital Strategies’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$485K	Buy	+11,353	New	+$616K	0.03%	280
2025 Q2	–	Sell	-40,448	Closed	-$4.08M	–	281
2025 Q1	$4.08M	Buy	+40,448	New	+$4.07M	0.38%	47
2024 Q4	–	Sell	-96,363	Closed	-$8.08M	–	270
2024 Q3	$8.08M	Buy	96,363 +53,993	+127%	+$4.26M	0.33%	74
2024 Q2	$3.26M	Buy	42,370 +10,058	+31%	+$736K	0.16%	148
2024 Q1	$2.21M	Sell	32,312 -19,421	-38%	-$1.25M	0.12%	181
2023 Q4	$2.99M	Buy	+51,733	New	+$2.76M	0.34%	80
2022 Q4	–	Sell	-58,112	Closed	-$2.25M	–	149
2022 Q3	$2.25M	Buy	+58,112	New	+$2.33M	0.79%	47

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Concentric Capital Strategies's BSX Position: Q2 2026 in Review

Concentric Capital Strategies opened a new position in Boston Scientific (BSX) in Q2 2026: 11,353 shares worth $485K. The stake represents 0.03% of the portfolio and ranks #280 among its holdings. This is a return to the name: Concentric Capital Strategies previously reported a position in BSX as recently as Q1 2025.

Concentric Capital Strategies first reported a position in BSX in Q3 2022 and has held it in 7 quarters since. The position peaked at $8.08M in Q3 2024. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Concentric Capital Strategies held 11,353 shares of Boston Scientific worth $485K as of Q2 2026.
Boston Scientific was a new Concentric Capital Strategies position in Q2 2026.
Boston Scientific made up 0.03% of Concentric Capital Strategies's portfolio in Q2 2026, its #280 holding.
Concentric Capital Strategies first reported a position in Boston Scientific in Q3 2022 and has held it in 7 quarters since.
Concentric Capital Strategies's Boston Scientific position peaked at $8.08M in Q3 2024.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.